According to this latest study, the 2021 growth of Small Molecule Injectable will have significant change from previous year. By the most conservative estimates of global Small Molecule Injectable market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Small Molecule Injectable market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Injectable market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Intravenous (IV)
Intramuscular (IM)
Subcutaneous (SC)
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Aurobindo Pharma Limited
Teva Pharmaceutical Industries Ltd.
Merck & Co. Inc.
AstraZeneca Plc
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Novartis AG
Baxter International
Fresenius Kabi
Cipla Ltd
Mylan N.V.
Sanofi S.A
Dr. Reddy's Laboratories Ltd
Table of Contents1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Molecule Injectable Consumption 2016-2026
2.1.2 Small Molecule Injectable Consumption CAGR by Region
2.2 Small Molecule Injectable Segment by Type
2.2.1 Intravenous (IV)
2.2.2 Intramuscular (IM)
2.2.3 Subcutaneous (SC)
2.3 Small Molecule Injectable Sales by Type
2.3.1 Global Small Molecule Injectable Sales Market Share by Type (2016-2021)
2.3.2 Global Small Molecule Injectable Revenue and Market Share by Type (2016-2021)
2.3.3 Global Small Molecule Injectable Sale Price by Type (2016-2021)
2.4 Small Molecule Injectable Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Small Molecule Injectable Sales by Application
2.5.1 Global Small Molecule Injectable Sale Market Share by Application (2016-2021)
2.5.2 Global Small Molecule Injectable Revenue and Market Share by Application (2016-2021)
2.5.3 Global Small Molecule Injectable Sale Price by Application (2016-2021)
3 Global Small Molecule Injectable by Company
3.1 Global Small Molecule Injectable Sales Market Share by Company
3.1.1 Global Small Molecule Injectable Sales by Company (2019-2021)
3.1.2 Global Small Molecule Injectable Sales Market Share by Company (2019-2021)
3.2 Global Small Molecule Injectable Revenue Market Share by Company
3.2.1 Global Small Molecule Injectable Revenue by Company (2019-2021)
3.2.2 Global Small Molecule Injectable Revenue Market Share by Company (2019-2021)
3.3 Global Small Molecule Injectable Sale Price by Company
3.4 Global Manufacturers Small Molecule Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Small Molecule Injectable Product Location Distribution
3.4.2 Players Small Molecule Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Small Molecule Injectable by Region
4.1 Global Small Molecule Injectable by Region
4.1.1 Global Small Molecule Injectable Sales by Region
4.1.2 Global Small Molecule Injectable Revenue by Region
4.2 Americas Small Molecule Injectable Sales Growth
4.3 APAC Small Molecule Injectable Sales Growth
4.4 Europe Small Molecule Injectable Sales Growth
4.5 Middle East & Africa Small Molecule Injectable Sales Growth
5 Americas
5.1 Americas Small Molecule Injectable Sales by Country
5.1.1 Americas Small Molecule Injectable Sales by Country (2016-2021)
5.1.2 Americas Small Molecule Injectable Revenue by Country (2016-2021)
5.2 Americas Small Molecule Injectable Sales by Type
5.3 Americas Small Molecule Injectable Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Injectable Sales by Region
6.1.1 APAC Small Molecule Injectable Sales by Region (2016-2021)
6.1.2 APAC Small Molecule Injectable Revenue by Region (2016-2021)
6.2 APAC Small Molecule Injectable Sales by Type
6.3 APAC Small Molecule Injectable Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Small Molecule Injectable by Country
7.1.1 Europe Small Molecule Injectable Sales by Country (2016-2021)
7.1.2 Europe Small Molecule Injectable Revenue by Country (2016-2021)
7.2 Europe Small Molecule Injectable Sales by Type
7.3 Europe Small Molecule Injectable Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule Injectable by Country
8.1.1 Middle East & Africa Small Molecule Injectable Sales by Country (2016-2021)
8.1.2 Middle East & Africa Small Molecule Injectable Revenue by Country (2016-2021)
8.2 Middle East & Africa Small Molecule Injectable Sales by Type
8.3 Middle East & Africa Small Molecule Injectable Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Small Molecule Injectable Distributors
10.3 Small Molecule Injectable Customer
11 Global Small Molecule Injectable Market Forecast
11.1 Global Small Molecule Injectable Forecast by Region
11.1.1 Global Small Molecule Injectable Forecast by Regions (2021-2026)
11.2.2 Global Small Molecule Injectable Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Small Molecule Injectable Forecast by Type
11.7 Global Small Molecule Injectable Forecast by Application
12 Key Players Analysis
12.1 Aurobindo Pharma Limited
12.1.1 Aurobindo Pharma Limited Company Information
12.1.2 Aurobindo Pharma Limited Small Molecule Injectable Product Offered
12.1.3 Aurobindo Pharma Limited Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Aurobindo Pharma Limited Main Business Overview
12.1.5 Aurobindo Pharma Limited Latest Developments
12.2 Teva Pharmaceutical Industries Ltd.
12.2.1 Teva Pharmaceutical Industries Ltd. Company Information
12.2.2 Teva Pharmaceutical Industries Ltd. Small Molecule Injectable Product Offered
12.2.3 Teva Pharmaceutical Industries Ltd. Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
12.2.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12.3 Merck & Co. Inc.
12.3.1 Merck & Co. Inc. Company Information
12.3.2 Merck & Co. Inc. Small Molecule Injectable Product Offered
12.3.3 Merck & Co. Inc. Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Merck & Co. Inc. Main Business Overview
12.3.5 Merck & Co. Inc. Latest Developments
12.4 AstraZeneca Plc
12.4.1 AstraZeneca Plc Company Information
12.4.2 AstraZeneca Plc Small Molecule Injectable Product Offered
12.4.3 AstraZeneca Plc Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 AstraZeneca Plc Main Business Overview
12.4.5 AstraZeneca Plc Latest Developments
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Company Information
12.5.2 Pfizer Inc. Small Molecule Injectable Product Offered
12.5.3 Pfizer Inc. Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Pfizer Inc. Main Business Overview
12.5.5 Pfizer Inc. Latest Developments
12.6 Sun Pharmaceutical Industries Ltd.
12.6.1 Sun Pharmaceutical Industries Ltd. Company Information
12.6.2 Sun Pharmaceutical Industries Ltd. Small Molecule Injectable Product Offered
12.6.3 Sun Pharmaceutical Industries Ltd. Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
12.6.5 Sun Pharmaceutical Industries Ltd. Latest Developments
12.7 Novartis AG
12.7.1 Novartis AG Company Information
12.7.2 Novartis AG Small Molecule Injectable Product Offered
12.7.3 Novartis AG Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Novartis AG Main Business Overview
12.7.5 Novartis AG Latest Developments
12.8 Baxter International
12.8.1 Baxter International Company Information
12.8.2 Baxter International Small Molecule Injectable Product Offered
12.8.3 Baxter International Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Baxter International Main Business Overview
12.8.5 Baxter International Latest Developments
12.9 Fresenius Kabi
12.9.1 Fresenius Kabi Company Information
12.9.2 Fresenius Kabi Small Molecule Injectable Product Offered
12.9.3 Fresenius Kabi Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Fresenius Kabi Main Business Overview
12.9.5 Fresenius Kabi Latest Developments
12.10 Cipla Ltd
12.10.1 Cipla Ltd Company Information
12.10.2 Cipla Ltd Small Molecule Injectable Product Offered
12.10.3 Cipla Ltd Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Cipla Ltd Main Business Overview
12.10.5 Cipla Ltd Latest Developments
12.11 Mylan N.V.
12.11.1 Mylan N.V. Company Information
12.11.2 Mylan N.V. Small Molecule Injectable Product Offered
12.11.3 Mylan N.V. Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Mylan N.V. Main Business Overview
12.11.5 Mylan N.V. Latest Developments
12.12 Sanofi S.A
12.12.1 Sanofi S.A Company Information
12.12.2 Sanofi S.A Small Molecule Injectable Product Offered
12.12.3 Sanofi S.A Small Molecule Injectable Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Sanofi S.A Main Business Overview
12.12.5 Sanofi S.A Latest Developments
12.13 Dr. Reddy